RecruitingNot applicableNCT07153939
Pivotal Study of the Velocity™ pAVF System
Studying Progressive non-infectious anterior vertebral fusion
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Venova Medical
- Intervention
- Velocity Percutaneous Arteriovenous Fistula(device)
- Enrollment
- 126 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2025 – 2030
Study locations (10)
- Trinity Research Group, Dothan, Alabama, United States
- West Coast Kidney Institute Concord, Concord, California, United States
- Apex Research, Riverside, California, United States
- Vascular and Embolization Specialists, Cocoa, Florida, United States
- Azura Vascular Care Jacksonville, Jacksonville, Florida, United States
- Surgical Specialists of Charlotte, Charlotte, North Carolina, United States
- Aqua Research, Houston, Texas, United States
- Humble Vascular Surgical Center, Humble, Texas, United States
- Fresenius Vascular Care San Antonio, San Antonio, Texas, United States
- San Antonio Surgical Center, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07153939 on ClinicalTrials.gov